Inhibikase Therapeutics, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US45719W2052
USD
1.58
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryInhibikase Therapeutics, Inc. VS Pharmaceuticals & Biotechnology
 
1D
0%
-0.51%
1W
-0.63%
-1.37%
1M
-18.97%
0.35%
YTD
-22.93%
0.54%
1Y
-30.4%
13.99%
3Y
105.49%
66.39%
5Y
-96.6%
77.77%
10Y
-96.6%
259.33%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-0.63%
0%
-0.63%
6 Months
-1.25%
0%
-1.25%
1 Year
-30.4%
0%
-30.4%
2 Years
-38.04%
0%
-38.04%
3 Years
105.49%
0%
105.49%
4 Years
-79.74%
0%
-79.74%
5 Years
-96.6%
0%
-96.6%

Inhibikase Therapeutics, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Risk Adjusted Returns v/s stock-summary